Cover Image
市場調查報告書

骨癌:全球臨床實驗檢討

Bone Cancer Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 212841
出版日期 內容資訊 英文 586 Pages
訂單完成後即時交付
價格
Back to Top
骨癌:全球臨床實驗檢討 Bone Cancer Global Clinical Trials Review, H1, 2017
出版日期: 2017年04月30日 內容資訊: 英文 586 Pages
簡介

本報告提供全球骨癌治療藥的臨床實驗資料,提供各國的趨勢,彙整臨床實驗數,潛力治療藥物,及主要企業和研究機關的臨床實驗狀況,為您概述為以下內容。

目錄

簡介

  • 骨癌
  • 報告指南

臨床實驗 各地區

  • 臨床實驗 各國
    • 對臨床實驗有所貢獻的前五國 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美
    • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
    • 對臨床實驗有所貢獻的前幾名國家 - 中南美

臨床實驗:G7 各國

臨床實驗:G7 各國 各臨床實驗狀態

臨床實驗:E7 各國

臨床實驗:E7 各國 各臨床實驗狀態

臨床實驗 各階段

  • 進行中的臨床實驗 各階段

臨床實驗 各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

主要的參與臨床實驗企業

潛力治療藥物

臨床實驗 簡介

  • 臨床實驗概要: 前幾名企業
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Bayer AG
    • 武田藥品工業
    • Merck & Co., Inc.
    • Pfizer Inc.
    • AstraZeneca PLC
    • Eli Lilly and Company
    • Algeta ASA
  • 臨床實驗概要: 最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • Children's Oncology Group
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Massachusetts General Hospital
    • European Organization for Research and Treatment of Cancer
    • Southwest Oncology Group
    • University Health Network
    • Stanford University

5個主要的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Bone Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Bone Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Bone Cancer Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 583

  • Abbreviations 583
  • Definitions 583
  • Research Methodology 584
  • Secondary Research 584
  • About GlobalData 585
  • Contact Us 585
  • Disclaimer 585
  • Source 586

List of Tables

List of Tables

  • Bone Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Bone Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
  • Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13
  • Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 17
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Bone Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

List of Figures

  • Bone Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Bone Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
  • Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 13
  • Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 17
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Bone Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
  • GlobalData Methodology 584
Back to Top